Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.
about
Markers of cholesterol transport are associated with amyloid deposition in the brain.Arterial stiffness and β-amyloid progression in nondemented elderly adults.Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome populationCognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjectsThe Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysisPlasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort studyComparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PETCognitive aging in persons with minimal amyloid-β and white matter hyperintensities.Classification of amyloid status using machine learning with histograms of oriented 3D gradients.AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.Amyloid-Beta Deposition is Associated with Increased Medial Temporal Lobe Activation during Memory Encoding in the Cognitively Normal Elderly.Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease.Impact of Amyloid Burden on Regional Functional Synchronization in the Cognitively Normal Older Adults.Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.Small-molecule PET Tracers for Imaging Proteinopathies.Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.Investigation of (11)C-PiB equivocal PET findings.Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype.Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging
P2860
Q30406139-CF931D38-86A0-4D7C-9B32-39156B37A9D6Q30409084-6E92D35F-05E2-4C77-A44A-9035764075BFQ30409644-1CEBE153-28EF-4764-8972-59218FF42666Q33753393-5DC63969-B42D-42D2-BB4D-065D58A60660Q34305075-10B982EF-CA5E-471F-AB98-13618955ADA4Q34555928-008239F6-BFEA-4D7A-A958-4BE665A228A5Q34989647-6E135C66-04D6-44C4-9952-3F4C526B516FQ35158547-00FF557D-69F3-4726-9453-77B16707ECF0Q35828096-800D8DD1-7DFC-4C00-8F9C-2F3646E6BEAFQ35900301-0F3BBDEB-D000-4281-924A-8C20927828BFQ36250470-5FC5378F-BCC1-4EFB-B93F-0A127E227755Q36361729-090E38B7-9DC3-4910-B495-D5BD4FBD036EQ36366578-55E61918-4D12-4FC8-A5FE-0BE0FAE19C8EQ36514158-78369DBA-8DD8-4793-8689-1E9CFB4310DBQ37252248-3CBA510E-11AB-4FB1-B371-C50AA9852CD9Q37497463-71B4E969-45E1-48A6-A4F9-BC94A8949ED3Q38653494-38204275-AE12-44EF-8F99-AC2C0BD01A26Q38675507-43E076BA-00E4-4AEB-8D03-E1B21C146D6BQ38761575-684350A3-AC37-4D2C-8E38-299BCB8C8179Q41046609-A6797122-3F84-4D37-BBFC-590F2AD1A85BQ47164226-890E9CF8-C328-4198-92D4-5AB5BDC9FC12Q47280353-4069682B-337C-45D7-A8D8-CA53586E618BQ47926474-7998223E-7CE0-4FD2-8D1D-FAA4A9D57037Q51746356-5479DAFC-A63D-410D-BE57-6A0BEE7033AFQ53042095-7786508D-E155-476B-B45E-E2F736EF6A68Q53395987-B6A7B98F-6944-49BB-A43E-A8A8B845D55DQ53397288-7F263A3E-974C-413C-88EB-A35D4FCEA1CFQ58560845-930FB8BF-AF3C-4252-A933-CD9579B88436
P2860
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Classification of amyloid-posi ...... d and quantitative approaches.
@ast
Classification of amyloid-posi ...... d and quantitative approaches.
@en
type
label
Classification of amyloid-posi ...... d and quantitative approaches.
@ast
Classification of amyloid-posi ...... d and quantitative approaches.
@en
prefLabel
Classification of amyloid-posi ...... d and quantitative approaches.
@ast
Classification of amyloid-posi ...... d and quantitative approaches.
@en
P2093
P2860
P50
P1433
P1476
Classification of amyloid-posi ...... ad and quantitative approaches
@en
P2093
Ann D Cohen
Beth Snitz
Chester A Mathis
Eric McDade
James M Mountz
Jeff Williamson
Judith A Saxton
Julie C Price
Lisa A Weissfeld
Oscar L Lopez
P2860
P304
P356
10.1016/J.NEUROIMAGE.2013.01.015
P407
P577
2013-01-24T00:00:00Z